Maintenance rituximab in Veterans with follicular lymphoma
Abstract Real‐world practice patterns and clinical outcomes in patients with follicular lymphoma (FL), including the adoption of maintenance rituximab (MR) therapy in the United States (US), have been reported in few studies since the release of the National LymphoCare Study almost a decade ago. We...
Main Authors: | Ahmad S. Halwani, Kelli M. Rasmussen, Vikas Patil, Deborah Morreall, Catherine Li, Christina Yong, Zachary Burningham, Keith Dawson, Anthony Masaquel, Kevin Henderson, Elisha DeLong‐Sieg, Brian C. Sauer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3420 |
Similar Items
-
Treatment Patterns and Outcomes in a Nationwide Cohort of Older and Younger Veterans with Waldenström Macroglobulinemia, 2006–2019
by: Hsu-Chih Chien, et al.
Published: (2021-04-01) -
Primary cutaneous T‐follicular helper lymphoma
by: Elena M. Fenu, et al.
Published: (2023-11-01) -
Cytokeratin‐positive follicular dendritic cell sarcoma: A mimic of carcinoma
by: Elizabeth Ricks, et al.
Published: (2022-02-01) -
Maintenance therapy in multiple myeloma
by: Jean-Luc Harousseau
Published: (2009-08-01) -
Provincial heterogeneity in the management of care cascade for hypertension, diabetes, and dyslipidaemia in China: Analysis of nationally representative population-based survey
by: Zhao, Yang, et al.
Published: (2022)